IP Library Granted Patent US 9,545,338
Granted Patent B2
US 9,545,338 · App. 12/217,285 · Granted Jan 17, 2017

System and method for improving the accommodative amplitude and increasing the refractive power of the human lens with a laser

Inventors: Rudolph W. Frey (Winter Park, FL); Gary P. Gray (Orlando, FL); Jerome R. Kuszak (Oak Park, IL)
Assignee: LENSAR, LLC.
A61F9/008A61F9/00838A61F9/00827A61F2009/0087A61F2009/00897
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,545,338
App. No.
12/217,285
Granted
Jan 17, 2017
Kind
B2
Abstract

A system and method for increasing the amplitude of accommodation and/or changing the refractive power of lens material of a natural crystalline lens is provided. Generally, there is provided methods and systems for delivering a laser beam to a lens of an eye in a plurality of patterns results in the increased accommodative amplitude and/or refractive power of the lens. There is further provided a system and method of treating presbyopia by increasing both the flexibility of the human lens and the depth of field of the eye.

Claims (23)

1. A method of treating presbyopia comprising:

increasing flexibility of a lens of an eye by applying a first laser shot pattern to the lens;

calculating a model of the lens, using-in-part data obtained from a light source, regarding a position of the lens; and

increasing a depth of field visualized by the human eye by applying a second laser shot pattern to the lens.

2. The method of claim 1 , wherein the second laser shot pattern provides an aperture for the lens of the human eye, wherein the aperture is formed from material comprising an opacified annulus of human lens material.

3. The method of claim 2 , wherein the second laser shot pattern creates the opacified annulus.

4. A method for treating presbyopia comprising:

providing an eye that has presbyopia;

calculating a model of a lens of the eye, using-in-part data regarding a position of the lens, the data obtained from a light source; and

providing a laser beam in a shot pattern to a portion of the lens, wherein the lens comprises an organelle degradation region and an organelle free region and the shot pattern consisting essentially of shots directed toward the organelle degradation region of the lens, wherein the shots directed toward the organelle degradation region of the lens treat the presbyopia of the eye.

5. A method for treating presbyopia comprising:

providing an eye that has presbyopia;

calculating a model of the lens of an eye, using-in-part data regarding the position of the lens, the data obtained from a light source; and

providing a laser beam in a shot pattern to a portion of a lens of the eye, wherein the lens comprises an organelle free region and the shot pattern consisting essentially of shots directed toward the organelle free region of the lens of the eye, wherein the shots directed toward the organelle free region of the lens treat the presbyopia of the eye.

6. The method of claim 1 , wherein the first laser shot pattern creates nested shells.

7. The method of claim 6 , wherein the first laser shot pattern creates cube shaped cuts.

8. The method of claim 1 , wherein the first laser shot pattern creates cube shaped cuts.

9. The method of claim 3 , wherein the second laser shot pattern opacities a portion of the lens to from about 20% to about 100% opacification.

10. The method of claim 3 , wherein the second laser shot pattern opacities a portion of the lens to at least about 90% opacification.

11. A method for treating presbyopia comprising:

providing an eye that has presbyopia;

calculating a model of a lens of the eye, using-in-part data regarding the position of the lens, the data obtained from a light source; and

providing a laser beam in a shot pattern to a portion of the lens, wherein the lens comprises an organelle degradation region and an organelle free region and the shot pattern consisting essentially of shots directed toward the organelle degradation region and organelle free region of the lens, wherein the shots directed toward the organelle degradation region and the organelle free region of the lens treat the presbyopia of the eye.

Assignments (10)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY COLLATERAL (RF 042446/0763) Recorded Jul 13, 2020
From: PDL BIOPHARMA, INC.
To: LENSAR, INC.
Reel/Frame 053197/0084 →
SECURITY INTEREST Recorded May 11, 2017
From: LENSAR, INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 042446/0763 →
SECURITY INTEREST Recorded Feb 21, 2017
From: LENSAR, INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 041773/0190 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2017
From: LENSAR, LLC
To: LENSAR, INC.
Reel/Frame 041258/0863 →
SECURITY INTEREST Recorded Dec 16, 2016
From: LENSAR, INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 040996/0190 →
CHANGE OF NAME Recorded Dec 18, 2015
From: LION BUYER, LLC
To: LENSAR, LLC
Reel/Frame 037330/0169 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2015
From: LENSAR, INC.
To: LION BUYER, LLC
Reel/Frame 037328/0670 →
SECURITY INTEREST Recorded Dec 15, 2015
From: LION BUYER, LLC
To: PDL BIOPHARMA, INC.
Reel/Frame 037301/0363 →
SECURITY AGREEMENT Recorded Oct 1, 2013
From: LENSAR, INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 031324/0917 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 23, 2008
From: FREY, RUDOLPH W.; GRAY, GARY P.; KUSZAK, JEROME R.
To: LENSAR, INC.
Reel/Frame 021765/0343 →
Continuity (7)
Continuation In Part PCTUS2007001353 · Jan 19, 2007
Continuation In Part 11414838 · May 1, 2006
Continuation In Part 11337127 · Jan 20, 2006
Continuation In Part 11414819 · May 1, 2006
Continuation In Part 11337127 · Jan 20, 2006
Related Publication 20100004643A1 · Jan 7, 2010
Related Publication 20140066908A9 · Mar 6, 2014